<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Bras Pneumol</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Bras Pneumol</journal-id>
      <journal-title-group>
        <journal-title>Jornal Brasileiro de Pneumologia : Publica&#xE7;a&#x30B;o Oficial da Sociedade Brasileira de Pneumologia e Tisilogia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1806-3713</issn>
      <issn pub-type="epub">1806-3756</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Pneumologia e Tisiologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24473771</article-id>
      <article-id pub-id-type="pmc">4075908</article-id>
      <article-id pub-id-type="publisher-id">S1806-37132013000600753</article-id>
      <article-id pub-id-type="doi">10.1590/S1806-37132013000600016</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Sarcomatoid carcinoma of the lung with brain
metastases</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>de Oliveira</surname>
            <given-names>Matheus Fernandes</given-names>
          </name>
          <role>Resident in Neurosurgery</role>
          <aff>Neurosurgery Residency Program, Department of
Neurosurgery, Hospital do Servidor P&#xFA;blico Estadual de S&#xE3;o Paulo, S&#xE3;o Paulo,
Brazil</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Watanabe</surname>
            <given-names>S&#xED;lvia Conde</given-names>
          </name>
          <role>Resident in Pathology</role>
          <aff>Pathology Residency Program, Department of
Pathology, Hospital do Servidor P&#xFA;blico Estadual de S&#xE3;o Paulo, S&#xE3;o Paulo, Brazil</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Andrade</surname>
            <given-names>Mara Patr&#xED;cia Guilhermina</given-names>
          </name>
          <role>Pathologist</role>
          <aff>Department of Pathology, Hospital do Servidor P&#xFA;blico
Estadual de S&#xE3;o Paulo, S&#xE3;o Paulo, Brazil</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rotta</surname>
            <given-names>Jos&#xE9; Marcus</given-names>
          </name>
          <role>Neurosurgeon</role>
          <aff>Department of Neurosurgery, Hospital do Servidor P&#xFA;blico
Estadual de S&#xE3;o Paulo, S&#xE3;o Paulo, Brazil</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pinto</surname>
            <given-names>Fernando Campos Gomes</given-names>
          </name>
          <role>Neurosurgeon</role>
          <aff>Department of Neurosurgery, Instituto de Assist&#xEA;ncia M&#xE9;dica
ao Servidor P&#xFA;blico Estadual, S&#xE3;o Paulo, Brazil</aff>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub-ppub">
        <season>Nov-Dec</season>
        <year>2013</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2013</year>
      </pub-date>
      <volume>39</volume>
      <issue>6</issue>
      <fpage>753</fpage>
      <lpage>756</lpage>
      <history>
        <date date-type="received">
          <day>03</day>
          <month>3</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>23</day>
          <month>3</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <counts>
        <fig-count count="2"/>
        <ref-count count="10"/>
        <page-count count="4"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>To the Editor:</title>
      <p>We report the case of a 61-year-old Brazilian female who presented with cough,
hemoptysis, and fever for seven days prior to evaluation. Her previous medical history
revealed that she was a heavy smoker (80 pack-years) and had systemic arterial
hypertension. No occupational exposures were reported. Physical examination was
unremarkable. Blood workup revealed leukocytosis (white blood cell count, 15,000). Chest
X-ray was also unremarkable, and the initial management was antibiotic treatment. A CT
of the chest was requested, which revealed a spiculated tumor mass of 5 cm in diameter
in the right upper lobe, as well as mediastinal lymphadenopathy. The patient was then
submitted to bronchoscopy, which was negative for neoplasms. The decision was to perform
pulmonary lobectomy.</p>
      <p>Gross pathology showed that the right upper lobe weighed 300 g and measured 18.5 &#xD7; 12.0
&#xD7; 3.5 cm. The cut surface revealed a poorly circumscribed, tan-gray, hemorrhagic lesion
measuring 7.0 &#xD7; 6.0 &#xD7; 3.8 cm that infiltrated into the visceral pleura. Histologically,
the tumor was composed of spindle-shaped cells with marked pleomorphism and abnormal
mitosis. These tumor cells displayed a sarcoma-like growth pattern with scarce
multinucleated giant cells. Multiple foci of necrosis were present. Squamous cell
carcinoma or adenocarcinoma areas were not observed. Immunohistochemical studies were
performed using the avidin-biotin-peroxidase complex method. The tumor cells were
positive for pan-cytokeratin (AE1/AE3), CK7, and epithelial membrane antigen (<xref ref-type="fig" rid="f01">Figure 1</xref>) but negative for other antibodies. The
pathology report revealed sarcomatoid carcinoma of the lung, with spindle cell features.
No lymph nodes were involved. The tumor-node-metastasis staging classification, based on
the findings, was T2bN0Mx.</p>
      <p>
<fig id="f01" orientation="portrait" position="float"><label>Figure 1</label><caption><title> Photomicrographs of pathological and immunohistochemical studies. In A,
pan-cytokeratin cytoplasmic positivity of the tumor cells (AE1/AE3
immunostaining; magnification, &#xD7;400). In B, tumor cells showing diffuse
positivity for CK7 (CK7 immunostaining; magnification, &#xD7;100). In C, carcinoma
cells showing strong positivity for epithelial membrane antigen in contrast
with inflammatory adjacent non-tumoral tissue (immunostaining; magnification,
&#xD7;100).</title></caption><graphic xlink:href="1806-3713-jbpneu-39-06-0753-gf01"/></fig>
</p>
      <p>Immediately after the surgery, the oncological evaluation was completed. Abdominal CT
and bone scintigraphy resulted normal. Chest CT scans revealed pneumothorax in the right
upper lobe in the site of the resected tumor. Radiotherapy and chemotherapy were
proposed. However, the patient was lost to follow-up, and no adjuvant treatment was
performed.</p>
      <p>After four months without any adjuvant therapy, the patient returned to the hospital
presenting with progressive, complete right hemiparesis and impaired verbal
expression/aphasia for 10 days. At admission to the neurosurgery ward, the patient was
alert and cooperative, with a Glasgow Coma Scale score of 15, the pupils were isochoric
and reactive to light, and the patient presented with a grade-4 right hemiparesis in
association with aphasia.</p>
      <p>The patient was promptly submitted to a neuroimaging study, which revealed three images
(one in the left inferior frontal gyrus and two in the right parietal cortex) of lesions
with different dimensions in the brain parenchyma that resembled tumor invasion (<xref ref-type="fig" rid="f02">Figure 2</xref>). </p>
      <p>
<fig id="f02" orientation="portrait" position="float"><label>Figure 2</label><caption><title> Neuroimaging scans. In A, a CT scan of the skull taken when the pulmonary
mass was discovered four months prior to the appearance of neurological
symptoms, which is apparently normal. In B, a CT scan of the skull taken four
months after readmission, when the patient presented with neurological
symptoms. In C-E, magnetic resonance imaging scans revealing details of the
metastatic spread and intense vasogenic edema.</title></caption><graphic xlink:href="1806-3713-jbpneu-39-06-0753-gf02"/></fig>
</p>
      <p>The neurosurgery staff decided to perform microsurgery for the resection of the larger
lesion in the left frontal gyrus and adjuvant radiosurgery of the other lesions.</p>
      <p>The resected specimen was sent to pathology. The microscopic findings were similar to
the sarcomatoid carcinoma of the lung, characterized by the proliferation of pleomorphic
spindle-shaped cells. An immunohistochemical study was performed and revealed focal
positivity of the tumor cells for CK7 and diffuse positivity for epithelial membrane
antigen. The microscopic and immunohistochemical findings were consistent with
metastatic sarcomatoid carcinoma. </p>
      <p>The patient was discharged without any postoperative complications; however, she was
rehospitalized one week later with progressive worsening of her general health status
and, two months after the surgery, she died, prior to performing any adjuvant
therapy.</p>
      <p>Sarcomatoid carcinoma of the lung is a rare tumor, showing a male-to-female ratio of
7.25:1.00. The mean and median age of the patients is 65 years, and the tumor accounts
for 0.1-0.3% of all lung cancers.(<xref rid="B01" ref-type="bibr"><sup>1</sup></xref>-<xref rid="B04" ref-type="bibr"><sup>4</sup></xref>) It arises
from the central airway in two-thirds of the patients and exhibits the morphology of
polypoid airway lesions.(<xref rid="B03" ref-type="bibr"><sup>3</sup></xref>)</p>
      <p>Sarcomatoid carcinoma most often presents as solitary masses in the upper lobes, with an
average size of 7 cm in diameter.(<xref rid="B04" ref-type="bibr"><sup>4</sup></xref>,<xref rid="B05" ref-type="bibr"><sup>5</sup></xref>) Parenchymal
masses appear as cavities with marked central necrosis and peripheral rim. The
association with smoking is strong.(<xref rid="B01" ref-type="bibr"><sup>1</sup></xref>-<xref rid="B04" ref-type="bibr"><sup>4</sup></xref>) The
treatment is essentially performed with surgical resection, chemotherapy and
radiotherapy being used as adjuvant therapy or in cases of poor surgical conditions,
since there seems to be little benefit.(<xref rid="B01" ref-type="bibr"><sup>1</sup></xref>-<xref rid="B04" ref-type="bibr"><sup>4</sup></xref>,<xref rid="B06" ref-type="bibr"><sup>6</sup></xref>,<xref rid="B07" ref-type="bibr"><sup>7</sup></xref>) The five-year survival for patients with sarcomatoid
carcinoma is approximately 20% (compared with 50% for those with non-small cell lung
cancer), and the median duration of survival is three months.(<xref rid="B01" ref-type="bibr"><sup>1</sup></xref>,<xref rid="B02" ref-type="bibr"><sup>2</sup></xref>,<xref rid="B05" ref-type="bibr"><sup>5</sup></xref>,<xref rid="B07" ref-type="bibr"><sup>7</sup></xref>)</p>
      <p>The probable pathogenesis of sarcomatoid carcinoma includes malignant transformation of
hamartoma, simultaneous malignant transformation of epithelial elements and stroma,
malignant transformation of cancer-derived stroma, sarcomatous change in carcinoma, and
carcinomatous change in sarcoma.(<xref rid="B02" ref-type="bibr"><sup>2</sup></xref>,<xref rid="B03" ref-type="bibr"><sup>3</sup></xref>)</p>
      <p>Although there are reports of systemic metastases, such as in the skin, stomach,
pancreas, esophagus, jejunum, rectum, kidneys, bones, and adrenal glands,(<xref rid="B04" ref-type="bibr"><sup>4</sup></xref>-<xref rid="B10" ref-type="bibr"><sup>10</sup></xref>) to our knowledge, only one report documented brain
metastases,(<xref rid="B01" ref-type="bibr"><sup>1</sup></xref>) especially because
of the aggressiveness and low survival time.</p>
      <p>Few reports have presented and discussed the presentation of metastatic sarcomatoid
carcinoma of the lung in the brain. In our case, we illustrate the presentation of brain
metastases in a patient who had been previously treated for sarcomatoid carcinoma of the
lung and highlight the need to consider the differential diagnosis of pulmonary cancer
and the aggressive features of sarcomatoid carcinoma. The treatment, in accordance with
current therapies in metastatic brain disease, consisted of the surgical resection of
the larger lesion and complementary radiosurgery in the surgical cavity, with the
resection of the two smaller lesions.(<xref rid="B01" ref-type="bibr"><sup>1</sup></xref>,<xref rid="B02" ref-type="bibr"><sup>2</sup></xref>,<xref rid="B10" ref-type="bibr"><sup>10</sup></xref>) However, due to the progressive
worsening of the general status of the patient, the radiosurgical treatment was not
performed, and the patient died two months after being diagnosed with brain
metastases.</p>
      <p>The early diagnosis and proper surgical and adjuvant therapy of the primary disease
might lead to prolonged survival, and physicians should be aware of the appearance of
metastatic symptoms of sarcomatoid carcinoma, such as neurological symptoms, which can
be prominent and misleading to other differential diagnoses.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>We would like to thank Drs. S&#xED;lvio Ten&#xF3;rio Gameleira Filho, J&#xE2;nio Alves Ferreira,
Larissa Prando Cau, Maria do Carmo Cruvinel, and Ester Nei Aparecida Martins Coletta for
their invaluable help with the present manuscript.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="B01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Franks</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Galvin</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Sarcomatoid carcinoma of the lung: histologic criteria
and common lesions in the differential diagnosis</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>2010</year>
          <volume>134</volume>
          <issue>1</issue>
          <fpage>49</fpage>
          <lpage>54</lpage>
          <pub-id pub-id-type="pmid">20073605</pub-id>
        </element-citation>
      </ref>
      <ref id="B02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Maeshima</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tajima</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>A resected case of pulmonary
carcinosarcoma</article-title>
          <source>Ann Thorac Cardiovasc Surg</source>
          <year>2010</year>
          <volume>16</volume>
          <issue>3</issue>
          <fpage>190</fpage>
          <lpage>193</lpage>
          <pub-id pub-id-type="pmid">20930681</pub-id>
        </element-citation>
      </ref>
      <ref id="B03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ito</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Oizumi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fukumoto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Harada</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ishida</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Fujita</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical characteristics of pleomorphic carcinoma of the
lung</article-title>
          <source>Lung Cancer</source>
          <year>2010</year>
          <volume>68</volume>
          <issue>2</issue>
          <fpage>204</fpage>
          <lpage>210</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.lungcan.2009.06.002">http://dx.doi.org/10.1016/j.lungcan.2009.06.002</ext-link>
          <pub-id pub-id-type="pmid">19577320</pub-id>
        </element-citation>
      </ref>
      <ref id="B04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mochizuki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ishii</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Nagai</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Nishimura</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mizuno</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pleomorphic carcinoma of the lung: clinicopathologic
characteristics of 70 cases</article-title>
          <source>Am J Surg Pathol</source>
          <year>2008</year>
          <volume>32</volume>
          <issue>11</issue>
          <fpage>1727</fpage>
          <lpage>1735</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/PAS.0b013e3181804302">http://dx.doi.org/10.1097/PAS.0b013e3181804302</ext-link>
          <pub-id pub-id-type="pmid">18769330</pub-id>
        </element-citation>
      </ref>
      <ref id="B05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rossi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Cavazza</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sturm</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Migaldi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Facciolongo</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Longo</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pulmonary carcinomas with pleomorphic, sarcomatoid, or
sarcomatous elements: a clinicopathologic and immunohistochemical study of 75
cases</article-title>
          <source>Am J Surg Pathol</source>
          <year>2003</year>
          <volume>27</volume>
          <issue>3</issue>
          <fpage>311</fpage>
          <lpage>324</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/00000478-200303000-00004">http://dx.doi.org/10.1097/00000478-200303000-00004</ext-link>
          <pub-id pub-id-type="pmid">12604887</pub-id>
        </element-citation>
      </ref>
      <ref id="B06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Zo</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>SW</given-names>
            </name>
          </person-group>
          <article-title>Initial presentation of lung sarcomatoid carcinoma as a
metastatic lesion in the mandibular gingiva</article-title>
          <source>J Periodontol</source>
          <year>2006</year>
          <volume>77</volume>
          <issue>4</issue>
          <fpage>734</fpage>
          <lpage>737</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1902/jop.2006.050137">http://dx.doi.org/10.1902/jop.2006.050137</ext-link>
          <pub-id pub-id-type="pmid">16584358</pub-id>
        </element-citation>
      </ref>
      <ref id="B07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Robbins</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Ryu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kalkanis</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cogan</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rock</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Movsas</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Radiosurgery to the surgical cavity as adjuvant therapy
for resected brain metastasis</article-title>
          <source>Neurosurgery</source>
          <year>2012</year>
          <volume>71</volume>
          <issue>5</issue>
          <fpage>937</fpage>
          <lpage>943</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1227/NEU.0b013e31826909f2">http://dx.doi.org/10.1227/NEU.0b013e31826909f2</ext-link>
          <pub-id pub-id-type="pmid">22806080</pub-id>
        </element-citation>
      </ref>
      <ref id="B08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Terada</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Sarcomatoid carcinoma of the lung presenting as a
cutaneous metastasis</article-title>
          <source>J Cutan Pathol</source>
          <year>2010</year>
          <volume>37</volume>
          <issue>4</issue>
          <fpage>482</fpage>
          <lpage>485</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1600-0560.2009.01292.x">http://dx.doi.org/10.1111/j.1600-0560.2009.01292.x</ext-link>
          <pub-id pub-id-type="pmid">19602061</pub-id>
        </element-citation>
      </ref>
      <ref id="B09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Travis</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Brambilla</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Noguchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nicholson</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Geisinger</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Yatabe</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>International association for the study of lung
cancer/american thoracic society/european respiratory society: international
multidisciplinary classification of lung adenocarcinoma</article-title>
          <source>J Thorac Oncol</source>
          <year>2011</year>
          <volume>6</volume>
          <issue>2</issue>
          <fpage>244</fpage>
          <lpage>285</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/JTO.0b013e318206a221">http://dx.doi.org/10.1097/JTO.0b013e318206a221</ext-link>
          <pub-id pub-id-type="pmid">21252716</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yendamuri</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Caty</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Pine</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Adem</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bogner</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Outcomes of sarcomatoid carcinoma of the lung: a
Surveillance, Epidemiology, and End Results Database analysis</article-title>
          <source>Surgery</source>
          <year>2012</year>
          <volume>152</volume>
          <issue>3</issue>
          <fpage>397</fpage>
          <lpage>402</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.surg.2012.05.007">http://dx.doi.org/10.1016/j.surg.2012.05.007</ext-link>
          <pub-id pub-id-type="pmid">22739072</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article id="S01" article-type="translation" xml:lang="pt">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Cartas ao Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Carcinoma sarcomatoide de pulm&#xE3;o com met&#xE1;stases
cerebrais</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Oliveira</surname>
            <given-names>Matheus Fernandes de</given-names>
          </name>
          <role>Residente em Neurocirurgia</role>
          <aff>Programa de Resid&#xEA;ncia em Neurocirurgia,
Departamento de Neurocirurgia, Hospital do Servidor P&#xFA;blico Estadual de S&#xE3;o Paulo, S&#xE3;o
Paulo (SP) Brasil</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Watanabe</surname>
            <given-names>S&#xED;lvia Conde</given-names>
          </name>
          <role>Residente em Patologia</role>
          <aff>Programa de Resid&#xEA;ncia em Patologia, Departamento
de Patologia, Hospital do Servidor P&#xFA;blico Estadual de S&#xE3;o Paulo, S&#xE3;o Paulo (SP)
Brasil</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Andrade</surname>
            <given-names>Mara Patr&#xED;cia Guilhermina de</given-names>
          </name>
          <role>Patologista</role>
          <aff>Departamento de Patologia, Hospital do Servidor P&#xFA;blico
Estadual de S&#xE3;o Paulo, S&#xE3;o Paulo (SP) Brasil</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rotta</surname>
            <given-names>Jos&#xE9; Marcus</given-names>
          </name>
          <role>Neurocirurgi&#xE3;o</role>
          <aff>Departamento de Neurocirurgia, Hospital do Servidor
P&#xFA;blico Estadual de S&#xE3;o Paulo, S&#xE3;o Paulo (SP) Brasil</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pinto</surname>
            <given-names>Fernando Campos Gomes</given-names>
          </name>
          <role>Neurocirurgi&#xE3;o</role>
          <aff>Departamento de Neurocirurgia, Instituto de Assist&#xEA;ncia
M&#xE9;dica ao Servidor P&#xFA;blico Estadual, S&#xE3;o Paulo (SP) Brasil</aff>
        </contrib>
      </contrib-group>
    </front-stub>
    <body>
      <sec>
        <title>Ao Editor:</title>
        <p>Relatamos o caso de uma brasileira de 61 anos de idade que apresentou tosse,
hemoptise e febre durante sete dias antes de ser avaliada. A hist&#xF3;ria m&#xE9;dica da
paciente revelou que se tratava de fumante pesada (80 anos-ma&#xE7;o) com hipertens&#xE3;o
arterial sist&#xEA;mica. N&#xE3;o houve relato de exposi&#xE7;&#xE3;o ocupacional. O exame f&#xED;sico n&#xE3;o
revelou nenhuma altera&#xE7;&#xE3;o digna de nota. O hemograma revelou leucocitose (15.000
leuc&#xF3;citos). A radiografia de t&#xF3;rax tamb&#xE9;m n&#xE3;o revelou nenhuma altera&#xE7;&#xE3;o digna de
nota. O tratamento inicial consistiu em antibioticoterapia. Solicitou-se uma TC de
t&#xF3;rax, que revelou uma massa tumoral espiculada de 5 cm de di&#xE2;metro no lobo superior
direito, al&#xE9;m de linfadenopatia mediastinal. A paciente foi ent&#xE3;o submetida a
broncoscopia, que foi negativa para neoplasia. Tomou-se a decis&#xE3;o de realizar uma
lobectomia pulmonar. </p>
        <p>O exame anatomopatol&#xF3;gico macrosc&#xF3;pico revelou que o lobo superior direito pesava 300
g e media 18,5 &#xD7; 12,0 &#xD7; 3,5 cm. A superf&#xED;cie de corte revelou uma les&#xE3;o hemorr&#xE1;gica
mal circunscrita, cinza-amarronzado, de 7,0 &#xD7; 6,0 &#xD7; 3,8 cm, infiltrada na pleura
visceral. Histologicamente, o tumor era composto por c&#xE9;lulas fusiformes com
pleomorfismo acentuado e mitose anormal. Essas c&#xE9;lulas tumorais exibiam um padr&#xE3;o de
crescimento semelhante ao do sarcoma, com poucas c&#xE9;lulas gigantes multinucleadas.
Havia m&#xFA;ltiplos focos de necrose. N&#xE3;o foram observadas &#xE1;reas de adenocarcinoma ou
carcinoma de c&#xE9;lulas escamosas. Estudos imuno-histoqu&#xED;micos foram realizados por meio
do m&#xE9;todo do complexo avidina-biotina-peroxidase. As c&#xE9;lulas tumorais foram positivas
para pancitoqueratina (AE1/AE3), CK7 e ant&#xED;geno da membrana epitelial (<xref ref-type="fig" rid="f03">Figura 1</xref>), mas negativas para outros anticorpos.
No laudo anatomopatol&#xF3;gico, registrou-se carcinoma sarcomatoide de pulm&#xE3;o, com
caracter&#xED;sticas de c&#xE9;lulas fusiformes. N&#xE3;o havia comprometimento de linfonodos.
Baseada nos achados, a classifica&#xE7;&#xE3;o segundo o sistema de estadiamento
tumor-n&#xF3;dulo-met&#xE1;stase foi T2bN0Mx. </p>
        <p>
<fig id="f03" orientation="portrait" position="float"><label>Figura 1</label><caption><title> Fotomicrografias de estudos patol&#xF3;gicos e imuno-histoqu&#xED;micos. Em A,
c&#xE9;lulas tumorais apresentando positividade citoplasm&#xE1;tica para
pancitoqueratina (imunocolora&#xE7;&#xE3;o para AE1/AE3; aumento, 400&#xD7;). Em B, c&#xE9;lulas
tumorais apresentando positividade difusa para CK7 (imunocolora&#xE7;&#xE3;o para CK7;
aumento, 100&#xD7;). Em C, c&#xE9;lulas de carcinoma exibindo forte positividade para
ant&#xED;geno da membrana epitelial, em contraste com o tecido inflamat&#xF3;rio n&#xE3;o
tumoral adjacente (imunocolora&#xE7;&#xE3;o; aumento, 100&#xD7;).</title></caption><graphic xlink:href="1806-3713-jbpneu-39-06-0753-gf01-pt"/></fig>
</p>
        <p>Imediatamente ap&#xF3;s a cirurgia, completou-se a avalia&#xE7;&#xE3;o oncol&#xF3;gica. A TC abdominal e
a cintilografia &#xF3;ssea resultaram normais. A TC de t&#xF3;rax revelou pneumot&#xF3;rax no lobo
superior direito no local do tumor ressecado. Foram propostas radioterapia e
quimioterapia. No entanto, houve perda de seguimento, e nenhum tratamento adjuvante
foi administrado. </p>
        <p>Depois de quatro meses sem qualquer terapia adjuvante, a paciente retornou ao
hospital com hemiparesia completa e progressiva &#xE0; direita e comunica&#xE7;&#xE3;o verbal
comprometida/afasia havia 10 dias. No momento da admiss&#xE3;o na enfermaria de
neurocirurgia, a paciente estava alerta e cooperativa (pontua&#xE7;&#xE3;o na Escala de Coma de
Glasgow: 15). As pupilas estavam isoc&#xF3;ricas e reagiam &#xE0; luz, e a paciente apresentava
hemiparesia direita grau 4 associada a afasia. </p>
        <p>A paciente foi prontamente submetida a um estudo de neuroimagem, que revelou tr&#xEA;s
imagens de les&#xF5;es (uma no giro frontal inferior esquerdo e duas no c&#xF3;rtex parietal
direito) de diferentes dimens&#xF5;es no par&#xEA;nquima cerebral, as quais se assemelhavam a
invas&#xE3;o tumoral (<xref ref-type="fig" rid="f04">Figura 2</xref>). </p>
        <p>
<fig id="f04" orientation="portrait" position="float"><label>Figura 2</label><caption><title> Neuroimagens. Em A, TC de cr&#xE2;nio, aparentemente normal, realizada
quando a massa pulmonar foi descoberta, quatro meses antes do aparecimento
de sintomas neurol&#xF3;gicos. Em B, TC de cr&#xE2;nio realizada quatro meses ap&#xF3;s a
readmiss&#xE3;o, quando a paciente apresentou sintomas neurol&#xF3;gicos. Em C-E,
imagens de resson&#xE2;ncia magn&#xE9;tica revelando detalhes da dissemina&#xE7;&#xE3;o
metast&#xE1;tica e intenso edema vasog&#xEA;nico.</title></caption><graphic xlink:href="1806-3713-jbpneu-39-06-0753-gf02-pt"/></fig>
</p>
        <p>A equipe de neurocirurgia decidiu realizar microcirurgia para a resse&#xE7;&#xE3;o da les&#xE3;o
maior no giro frontal esquerdo e radiocirurgia adjuvante das demais les&#xF5;es. </p>
        <p>O esp&#xE9;cime ressecado foi enviado &#xE0; patologia. Os achados microsc&#xF3;picos foram
semelhantes aos do carcinoma sarcomatoide de pulm&#xE3;o, caracterizados pela prolifera&#xE7;&#xE3;o
de c&#xE9;lulas fusiformes pleom&#xF3;rficas. Um estudo imuno-histoqu&#xED;mico foi realizado e
revelou positividade focal das c&#xE9;lulas tumorais para CK7 e positividade difusa para
ant&#xED;geno da membrana epitelial. Os achados microsc&#xF3;picos e imuno-histoqu&#xED;micos foram
consistentes com carcinoma sarcomatoide metast&#xE1;tico. </p>
        <p>A paciente recebeu alta sem complica&#xE7;&#xF5;es p&#xF3;s-operat&#xF3;rias; no entanto, foi
hospitalizada novamente uma semana depois, com piora progressiva de seu estado geral
de sa&#xFA;de, e morreu dois meses ap&#xF3;s a cirurgia, antes que se realizasse qualquer
terapia adjuvante. </p>
        <p>O carcinoma sarcomatoide de pulm&#xE3;o &#xE9; um tumor raro; a raz&#xE3;o entre os g&#xEA;neros
masculino e feminino &#xE9; de 7,25:1,00. A m&#xE9;dia e mediana de idade dos pacientes &#xE9; de 65
anos, e o tumor corresponde a 0,1-0,3% de todos os c&#xE2;nceres de pulm&#xE3;o.(<xref rid="B01" ref-type="bibr"><sup>1</sup></xref>-<xref rid="B04" ref-type="bibr"><sup>4</sup></xref>) Prov&#xE9;m da via a&#xE9;rea central em dois ter&#xE7;os dos pacientes
e apresenta a morfologia das les&#xF5;es polipoides das vias a&#xE9;reas.(<xref rid="B03" ref-type="bibr"><sup>3</sup></xref>)</p>
        <p>O carcinoma sarcomatoide mais comumente se apresenta na forma de massas solit&#xE1;rias
nos lobos superiores, com um tamanho m&#xE9;dio de 7 cm de di&#xE2;metro.(<xref rid="B04" ref-type="bibr"><sup>4</sup></xref>,<xref rid="B05" ref-type="bibr"><sup>5</sup></xref>)
Massas parenquimatosas aparecem na forma de cavidades com necrose central acentuada e
borda perif&#xE9;rica. A associa&#xE7;&#xE3;o com o tabagismo &#xE9; forte.(<xref rid="B01" ref-type="bibr"><sup>1</sup></xref>-<xref rid="B04" ref-type="bibr"><sup>4</sup></xref>)
O tratamento consiste essencialmente em resse&#xE7;&#xE3;o cir&#xFA;rgica; a quimioterapia e a
radioterapia s&#xE3;o usadas como terapia adjuvante ou em caso de m&#xE1;s condi&#xE7;&#xF5;es
cir&#xFA;rgicas, pois o benef&#xED;cio &#xE9; aparentemente pequeno.(<xref rid="B01" ref-type="bibr"><sup>1</sup></xref>-<xref rid="B04" ref-type="bibr"><sup>4</sup></xref>,<xref rid="B06" ref-type="bibr"><sup>6</sup></xref>,<xref rid="B07" ref-type="bibr"><sup>7</sup></xref>) A taxa de sobrevida em cinco anos para pacientes com
carcinoma sarcomatoide &#xE9; de aproximadamente 20% (contra 50% para aqueles com c&#xE2;ncer
pulmonar de c&#xE9;lulas n&#xE3;o pequenas), e a mediana da sobrevida &#xE9; de tr&#xEA;s meses.(<xref rid="B01" ref-type="bibr"><sup>1</sup></xref>,<xref rid="B02" ref-type="bibr"><sup>2</sup></xref>,<xref rid="B05" ref-type="bibr"><sup>5</sup></xref>,<xref rid="B07" ref-type="bibr"><sup>7</sup></xref>)</p>
        <p>A prov&#xE1;vel patog&#xEA;nese do carcinoma sarcomatoide inclui transforma&#xE7;&#xE3;o maligna de
hamartoma, transforma&#xE7;&#xE3;o maligna simult&#xE2;nea de elementos epiteliais e estroma,
transforma&#xE7;&#xE3;o maligna de estroma derivado de c&#xE2;ncer, transforma&#xE7;&#xE3;o sarcomatosa de
carcinoma e transforma&#xE7;&#xE3;o carcinomatosa de sarcoma.(<xref rid="B02" ref-type="bibr"><sup>2</sup></xref>,<xref rid="B03" ref-type="bibr"><sup>3</sup></xref>)</p>
        <p>Embora haja relatos de met&#xE1;stases sist&#xEA;micas (na pele, no est&#xF4;mago, no p&#xE2;ncreas, no
es&#xF4;fago, no jejuno, no reto, nos rins, em ossos e nas gl&#xE2;ndulas adrenais, por
exemplo),(<xref rid="B04" ref-type="bibr"><sup>4</sup></xref>-<xref rid="B10" ref-type="bibr"><sup>10</sup></xref>) at&#xE9; onde sabemos, apenas um relato
documentou met&#xE1;stases cerebrais,(<xref rid="B01" ref-type="bibr"><sup>1</sup></xref>)
especialmente por causa da agressividade e da sobrevida curta. </p>
        <p>Poucos relatos apresentaram e discutiram a apresenta&#xE7;&#xE3;o de carcinoma sarcomatoide
metast&#xE1;tico de pulm&#xE3;o no c&#xE9;rebro. No caso descrito aqui, ilustramos a apresenta&#xE7;&#xE3;o de
met&#xE1;stases cerebrais em uma paciente que havia recebido tratamento para carcinoma
sarcomatoide de pulm&#xE3;o e ressaltamos a necessidade de considerar o diagn&#xF3;stico
diferencial de c&#xE2;ncer de pulm&#xE3;o e as caracter&#xED;sticas agressivas do carcinoma
sarcomatoide. O tratamento, conforme as terapias atuais para doen&#xE7;a metast&#xE1;tica
cerebral, consistiu em resse&#xE7;&#xE3;o cir&#xFA;rgica da les&#xE3;o maior e radiocirurgia complementar
na cavidade cir&#xFA;rgica, com a resse&#xE7;&#xE3;o das duas les&#xF5;es menores.(<xref rid="B01" ref-type="bibr"><sup>1</sup></xref>,<xref rid="B02" ref-type="bibr"><sup>2</sup></xref>,<xref rid="B10" ref-type="bibr"><sup>10</sup></xref>) No
entanto, em virtude da piora progressiva do estado geral da paciente, o tratamento
radiocir&#xFA;rgico n&#xE3;o foi realizado, e a paciente morreu dois meses depois de ter
recebido o diagn&#xF3;stico de met&#xE1;stases cerebrais. </p>
        <p>O diagn&#xF3;stico precoce e o tratamento cir&#xFA;rgico e adjuvante adequado da doen&#xE7;a
prim&#xE1;ria podem resultar em maior sobrevida, e os m&#xE9;dicos devem estar cientes do
aparecimento de sintomas metast&#xE1;ticos de carcinoma sarcomatoide, tais como sintomas
neurol&#xF3;gicos, que podem ser pronunciados e enganosos, levando a outros diagn&#xF3;sticos
diferenciais. </p>
      </sec>
    </body>
    <back>
      <ack>
        <title>Agradecimentos</title>
        <p>Gostar&#xED;amos de agradecer aos Drs. S&#xED;lvio Ten&#xF3;rio Gameleira Filho, J&#xE2;nio Alves
Ferreira, Larissa Prando Cau, Maria do Carmo Cruvinel e Ester Nei Aparecida Martins
Coletta sua inestim&#xE1;vel ajuda com o presente manuscrito.</p>
      </ack>
    </back>
  </sub-article>
</article>
</pmc-articleset>
